A TDO inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

LM-10

Item No. 36291

Technical Information
Formal Name
6-fluoro-3-[(1E)-2-(2H-tetrazol-5-yl)ethenyl]-1H-indole
CAS Number
1316695-35-8
Molecular Formula
C11H8FN5
Formula Weight
Purity
≥98%
Formulation
A solid
DMF: 1 mg/mlDMSO: 10 mg/ml
λmax
226, 328 nm
SMILES
FC1=CC=C2C(/C=C/C3=NN=NN3)=CNC2=C1
InChi Code
InChI=1S/C11H8FN5/c12-8-2-3-9-7(6-13-10(9)5-8)1-4-11-14-16-17-15-11/h1-6,13H,(H,14,15,16,17)/b4-1+
InChi Key
JDBSZVDIUIRSDG-DAFODLJHSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    LM-10 is an inhibitor of tryptophan 2,3-dioxygenase (TDO; IC50 = 2 µM).1 It is selective for TDO over indoleamine 2,3-dioxygenase (IDO), monoamine oxidase A (MAO-A), and MAO-B, as well as a panel of various receptors and transporters, at 10 µM. LM-10 (1 mg/ml in the drinking water) reverses tumoral immune resistance in a TDO-overexpressing P815B mastocytoma syngeneic model using mice immunized with the P815 antigen P1A.2 Oral administration of LM-10 (50 mg/kg) prevents decreases in the number of dopaminergic neurons and increases in microglial cell volume, a marker of neuroinflammation, in the substantia nigra and inhibits decreases in intestinal transit in a mouse model of Parkinson’s disease induced by rotenone (Item No. 13995).3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Dolušić, E., Larrieu, P., Moineaux, L., et alTryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as potential anticancer immunomodulators. J. Med. Chem. 54(15), 5320-5334 (2011).

    2. Pilotte, L., Larrieu, P., Stroobant, V., et alReversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proc. Natl. Acad. Sci. USA 109(7), 2497-2502 (2012).

    3. Perez-Pardo, P., Grobben, Y., Willemsen-Seegers, N., et alPharmacological validation of TDO as a target for Parkinson’s disease. FEBS J. 288(14), 4311-4331 (2021).